Like everyone else, I’ve spent the past few weeks mesmerized by images of health care workers receiving the first doses of the vaccine. I’ve rejoiced at social media posts announcing a sibling, a partner or a best friend who’s first in line. “My sister, who’s been treating Covid patients this year and is spending the holidays alone to keep the rest of us safe, just told our fam group chat she’s getting the vaccine this week,” journalist Connie Wang tweeted. “The collective relief and joy we feel is inexplicable.”
My sister, who’s been treating COVID patients this year and is spending the holidays alone to keep the rest of us safe, just told our fam group chat she’s getting the vaccine this week. The collective relief and joy we feel is inexplicable.
— Connie Wang (@conniewang) December 15, 2020
We’re nearing the end of a movie whose driving narrative has been “get a vaccine!” The trials were successful, the FDA issued emergency use authorization, the world rejoiced, the first doses were administered in a flurry of joy — and then the credits rolled. Presumably, life goes back to normal. But when, and how?
Placing faith in an organized, efficient, timely distribution of the vaccine doesn’t just feel like folly. It feels psychologically reckless.
We’ve got not just one, but two viable vaccines (with a third reportedly pending). But like everything else related to the government’s handling of Covid-19, the plans for the vaccine’s distribution are opaque, piecemeal and largely delegated to the discretion of individual states. After the initial distribution to front-line health care workers, the next few months are poised to be a “veritable land rush for Covid shots” as various industries and employers lobby for their employees to be next in line.
You can use a tool like this one to try to figure out where you are in the prioritized list, but it’s all relative. If you live in my hometown of Lewiston, Idaho, and are over 65, there is a lot that depends on whether your health conditions qualify you as “high risk.” And then there’s all the mitigating factors: Will there be adequate refrigeration? How will we reach the population that isn’t already calling their doctors, eager to be first in line? Is there even a plan, let alone the sort of detailed, dynamic plan that a massive distribution requires? What about the equally important distribution of the second dose? As the writer Zeynep Tufekci recently put it, will the U.S. “snatch defeat from the jaws of vaccine victory?”
“Few people across the country have a clear idea of how exactly the Covid-19 vaccine supply chains will be organized,” Bruce Y. Lee, who has worked in vaccine distribution for over 15 years, recently wrote in StatNews. “Vaccine chains have historically been neglected and underappreciated.”
When I try to fast-forward the tape of this pandemic, I can’t make the scenes of the future into anything coherent.
Yes, a new administration will be in charge at the federal level. It’s comforting, even thrilling, that they believe in science — and have a comparatively detailed plan for how to combat the pandemic moving forward. But like so many other Americans, my faith in our government’s ability to successfully execute any plan in relation to the pandemic isn’t just compromised. It’s gone.
On the federal, state and local level, we’ve bungled testing and messaging. We’ve repeatedly privileged businesses over human life. Congress has failed to pass substantive, lasting relief for the millions of families who are suffering, experiencing food insecurity, or facing eviction. It’s taken months for people to access unemployment benefits through an understaffed, labyrinthian system.
Just recently, the public learned that the U.S. government had previously refused the option of purchasing an additional 100 million doses of the Pfizer vaccine, raising questions of a potential “vaccine cliff” in which millions would wait — perhaps for months — for supply to catch up.
But to those with power, money and influence, rules can always be bent. California’s stern messaging about serving the neediest first hasn’t stopped the rich from trying to leap ahead of teachers, farmworkers and firefighters.
Dr. Jeff Toll, who has admitting privileges at Cedars-Sinai Medical Center, one of the first hospitals to stock the vaccine, recalled a patient asking: “If I donate $25,000 to Cedars, would that help me get in line?’” Toll said no.








